According to Nektar Therapeutics 's latest financial reports the company's current earnings are โน93.13 Million. In 2023 the company made an earning of -โน23.8 Billion, an increase over its 2022 earnings that were of -โน31.45 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -โน14.04 Billion | -41% |
2023 | -โน23.8 Billion | -24.31% |
2022 | -โน31.45 Billion | -30.25% |
2021 | -โน45.08 Billion | 17.87% |
2020 | -โน38.25 Billion | 0.88% |
2019 | -โน37.91 Billion | -164.46% |
2018 | โน58.81 B | -810.61% |
2017 | -โน8.28 Billion | -37.06% |
2016 | -โน13.15 Billion | 89.22% |
2015 | -โน6.95 Billion | 48.22% |
2014 | -โน4.69 Billion | -65.93% |
2013 | -โน13.77 Billion | -6.81% |
2012 | -โน14.77 Billion | 28.95% |
2011 | -โน11.46 Billion | 258.8% |
2010 | -โน3.2 Billion | -63.94% |
2009 | -โน8.86 Billion | -392.45% |
2008 | โน3.02 B | -211.74% |
2007 | -โน2.71 Billion | -79.57% |
2006 | -โน13.27 Billion | -16.9% |
2005 | -โน15.96 Billion | 81.53% |
2004 | -โน8.8 Billion | 54.19% |
2003 | -โน5.71 Billion | -33.87% |
2002 | -โน8.63 Billion | -9.6% |
2001 | -โน9.54 Billion | 73.39% |
2000 | -โน5.51 Billion | 108.9% |
1999 | -โน2.64 Billion | 39.48% |
1998 | -โน1.89 Billion | 60.02% |
1997 | -โน1.18 Billion | 18.05% |
1996 | -โน1 Billion | 31.82% |
1995 | -โน0.76 Billion | 57.14% |
1994 | -โน0.49 Billion |